With this acquisition, Aster DM Healthcare will own 100% of the target company, from the 87% stake it previously held. The transaction will be completed in two tranches and the indicative time period for completion of the acquisition is December 31, 2025.
The transaction is not classified as a related-party deal, as the promoters and group companies have no interest in Aster Aadhar outside its subsidiary status.
Also Read: Aster DM Healthcare to build ₹220 crore women & children’s hospital in Hyderabad
The 254-bed Aster Aadhar Hospital, Kolhapur is the city’s most comprehensive multi-speciality hospital. It is the first hospital in the region to acquire the prestigious NABH Accreditation— the gold standard for quality healthcare.
With 25+ specialties offered along with a panel of leading doctors and dedicated support staff, the hospital puts compassionate, quality care at the forefront.
“Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. Over the next 5 years i.e. FY25-FY29, the India business is set to achieve revenue CAGR 18%-20% YoY growth driven by an increased occupancy and addition of capacity.
Also Read: Aster DM Healthcare shares are the top Nifty 500 gainers after a 10% surge post Q2 results
The operating EBITDA margin is expected to reach a level of ~23%-25% over the next 4-5 years,” it added. Shares of Aster DM Healthcare Ltd ended at ₹439.75, up by ₹0.15, or 0.034% on the BSE.
